在2026年进行子宫内膜癌治疗
Victoria E Rodriguez1, Miles Morrow2, Rajeshree Rajpara3
1Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles.
Current opinion in obstetrics & gynecology
|November 19, 2025
概括
子宫内膜癌治疗的进步,包括修订的分期和免疫疗法,正在改善结果. 然而,正在进行的研究对于解决这种不断上升的癌症的剩余挑战至关重要.
科学领域:
- 妇科 妇科医生 妇科
- 在瘤学瘤学.
背景情况:
- 子宫内膜癌的发病率正在上升,突出显示需要创新的诊断和治疗策略.
- 近年来,人们在了解子宫内膜癌生物学和患者反应方面取得了重大进展.
研究的目的:
- 审查最近在子宫内膜癌诊断和治疗方面的进展.
- 突出治疗子宫内膜癌的新方法,包括生育能力保护和免疫疗法.
主要方法:
- 关于子宫内膜癌分期,生物标志物和治疗方法的最新文献的综述.
- 分析新的治疗方案,包括免疫疗法和FDA批准的复发性疾病治疗方法.
主要成果:
- 实施对子宫内膜癌的修订后的分期系统.
- 确定影响瘤生物学和治疗疗效的生物标志物和因素.
- 在符合条件的患者的生育保存选择方面取得的进展.
- 对免疫疗法进行广泛的研究,包括检查点抑制剂,用于晚期或复发的子宫内膜癌.
- 美国食品和药物管理局对新疗法的批准改善了复发性子宫内膜癌的治疗结果.
结论:
- 对子宫内膜癌治疗的显著改进导致了生存率的增加和更好的患者结果.
- 尽管取得了进展,但仍然存在未满足的需求,需要在2026年以后继续进行研究和开发.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936


